NSPR — InspireMD, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1433607 ·
Last close
$0.65
Market Cap
$30.45M
52W High
$2.17
52W Low
$0.43
ADV30
379,855
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 1,771,000 | -774,000 | -14,445,000 | -14,324,000 | 44,641,000 | 15,149,000 | 13,130,000 |
| Mar 2026 | 3,398,000 | 687,000 | -13,978,000 | -13,689,000 | 56,471,000 | 11,362,000 | 12,854,000 |
| Dec 2025 | 3,149,000 | 1,180,000 | -12,084,000 | -11,761,000 | 69,404,000 | 8,939,000 | 14,203,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-41,210,000
Investing CF
$-8,152,000
Financing CF
$52,926,000
CapEx
$-1,251,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.64
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-330,305,000
Inventory
$2,701,000
Receivables
$2,408,000
ST Investments
$15,272,000
EBIT TTM
$-53,558,000
Pretax Income TTM
$-52,419,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$10,841,000
EBITDA
$-52,980,000
Free Cash Flow
$-23,110,750
Enterprise Value
$9,325,754
Total Cash
$30,421,000
Total Debt
$3,025,000
Shares Out
46,838,962
Trailing EPS
$-0.61
Book Value
$0.67
ROE
-202.8%
ROA
-85.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,979,000 | -49,614,000 | -48,786,000 | 69,404,000 | 14,203,000 | 55,201,000 | -35,103,000 |
| Dec 2024 | 7,009,000 | -33,503,000 | -32,005,000 | 46,807,000 | 10,721,000 | 36,086,000 | -21,868,000 |
| Dec 2023 | 6,205,000 | -21,143,000 | -19,916,000 | 47,643,000 | 8,142,000 | 39,501,000 | -16,376,000 |
| Dec 2022 | 5,171,000 | -18,713,000 | -18,491,000 | 24,653,000 | 7,260,000 | 17,393,000 | -15,542,000 |
TTM Snapshot
Revenues TTM
$10,841,000
NetIncome TTM
$-52,482,000
OpCashFlow TTM
—
Assets (Latest)
$44,641,000
Forward EPS
$-0.48
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NEPH | NEPHROS INC | $31.52M | $2.90 | — |
| XTNT | Xtant Medical Holdings, Inc. | $28.79M | $0.21 | — |
| IDXG | INTERPACE BIOSCIENCES, INC. | $33.24M | $6.00 | — |
| TELA | TELA Bio, Inc. | $34.44M | $0.76 | — |
| DAVI | DAVION HEALTHCARE PLC | $25.75M | $1.03 | — |
News headlines (Yahoo Finance, 1h cache)
InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard® Prime TransCarotid Stent System
2026-11-18 21:30 · Yahoo
InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD’s CGuard Prime Carotid Stent Platform
2026-11-17 21:30 · Yahoo
InspireMD (NSPR) Upgraded to Buy: Here's Why
2026-11-17 16:00 · Yahoo
InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026
2026-11-16 21:05 · Yahoo
InspireMD Announces Pricing of $37.5 Million Public Offering
2026-11-13 13:12 · Yahoo
InspireMD (NSPR) Q3 2026 Earnings Call Transcript
2026-11-13 08:13 · Yahoo
InspireMD Inc (NSPR) (Q3 2026) Earnings Call Highlights: FDA Nod for CGuard Prime Reopens US ...
2026-11-13 05:04 · Yahoo
InspireMD, Inc. (NSPR) Reports Q3 Loss, Beats Revenue Estimates
2026-11-12 21:25 · Yahoo
InspireMD Announces Proposed Public Offering
2026-11-12 21:15 · Yahoo
InspireMD Reports Third Quarter 2026 Financial Results
2026-11-12 21:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.